{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:14:07Z","timestamp":1763018047520,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.amjcard.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T11:06:58Z","timestamp":1563188818000},"page":"995-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease"],"prefix":"10.1016","volume":"124","author":[{"given":"Alanna M.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Killian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri L.","family":"Monda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan A.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Okerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.07.002_bib0001","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0002","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2010.11.006","article-title":"Achieving optimal lipid goals in patients with coronary artery disease","volume":"107","author":"Karalis","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0003","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjcard.2014.10.021","article-title":"Frequency of high-risk patients not receiving high-potency statin (from a large managed care database)","volume":"115","author":"Rodriguez","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jacl.2013.09.009","article-title":"Therapeutic practice patterns related to statin potency and ezetimibe\/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease","volume":"8","author":"Toth","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0005","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jacc.2015.08.042","article-title":"Trends in the use of nonstatin lipid-lowering therapy among patients with coronary heart disease: a retrospective cohort study in the Medicare population 2007 to 2011","volume":"66","author":"Bittner","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1370\/afm.1641","article-title":"Cardiovascular risk and statin use in the United States","volume":"12","author":"Johansen","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2840-10-31","article-title":"Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008","volume":"10","author":"Kuznik","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0008","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.amjcard.2016.08.065","article-title":"Decade-long trends (2001 to 2011) in the use of evidence-based medical therapies at the time of hospital discharge for patients surviving acute myocardial infarction","volume":"118","author":"Makam","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2015.03.020","article-title":"Statin prescribing patterns: an analysis of data from patients with diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey databases, 2005-2010","volume":"37","author":"Pauff","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/clc.22503","article-title":"Statin use and its facility-level variation in patients with diabetes: insight from the Veterans Affairs national database","volume":"39","author":"Pokharel","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0011","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/clc.22428","article-title":"Burden of first and recurrent cardiovascular events among patients with hyperlipidemia","volume":"38","author":"Punekar","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0012","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCOUTCOMES.113.000112","article-title":"Trends in vascular risk factor treatment and control in US stroke survivors: the National Health and Nutrition Examination Surveys (1999-2010)","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SMJ.0b013e318259bad3","article-title":"Overtreatment and undertreatment of hyperlipidemia in the outpatient setting","volume":"105","author":"Verma","year":"2012","journal-title":"South Med J"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0014","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0016","unstructured":"Centers for Medicare and Medicaid Chronic Conditions Data Warehouse (CCW), CCW condition algorithms. https:\/\/www.ccwdata.org\/web\/guest\/condition-categories. (Accessed 25 June 2019)."},{"key":"10.1016\/j.amjcard.2019.07.002_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2018.02.019","article-title":"Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999-2014","volume":"139","author":"Gu","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0018","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jacl.2014.02.012","article-title":"The diabetes subpanel of the national lipid association expert panel. An assessment by the statin diabetes safety task force: 2014 update","volume":"8","author":"Maki","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0021","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2337\/diacare.28.5.1151","article-title":"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial\u2013lipid-lowering arm (ASCOT-LLA)","volume":"28","author":"Sever","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0022","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0023","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/CIRCULATIONAHA.113.003589","article-title":"Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction","volume":"129","author":"Arnold","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacc.2010.05.008","article-title":"Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention","volume":"56","author":"Roe","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0025","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","article-title":"Non-adherence to statin therapy: a major challenge for preventive cardiology","volume":"10","author":"Bates","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0026","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/glx169","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0028","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1331\/JAPhA.2014.13195","article-title":"Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study","volume":"54","author":"Schmittdiel","year":"2014","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0029","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.2337\/dc18-S008","article-title":"8. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2019.07.002_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St. Sauver","year":"2012","journal-title":"Mayo Clin Proc"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919307623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919307623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:30:15Z","timestamp":1757572215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919307623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0002914919307623"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.002","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}